Falciparum malaria vaccine (Swiss TPH Institute/Telormedix)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFalciparum malaria vaccine (Swiss TPH Institute/Telormedix)
Drug Alias NameTMX 201 adjuvant-based Malaria vaccine - Swiss TPH Institute/Telormedix
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 7 modulatorsImmunostimulants
TargetsToll like receptor 7
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSwiss Tropical InstituteTelormedix Sa
China Registration ClassN/A

Develop Information

Active CompaniesTelormedix SaSwiss Tropical Institute
Inactive CompaniesN/A
Active IndicationsMalaria, Falciparum
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A